US Drug Recall Register
Class III · Low risk Terminated Initiated May 18, 2016 (10 years ago)

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Tablet/Capsule Specifications

What was recalled

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.

Recalling firm
Teva North America
NDC code
0093-7440-01
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1449-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Divalproex recalls

See all